Previous 10 | Next 10 |
2024-02-10 08:14:00 ET Stock Traders Daily has produced this trading report using a proprietary method. This methodology seeks to optimize the entry and exit levels to maximize results and limit risk, and it is also applied to Index options, ETFs, and futures for our subscribers. This...
2024-02-09 17:10:51 ET More on IGM Biosciences IGM Biosciences: A New Approach To Antibodies, But Not A Value Right Now IGM Biosciences to cut 22% of workforce, shut down blood cancer programs IGM Biosciences GAAP EPS of -$1.04 beats by $0.21, revenue of $0.51M misse...
2024-02-09 10:00:22 ET More on Health Care Select Sector SPDR Healthcare In 2024: Navigating The Biopharma Bull Run XLV Likely Back To Outperforming XLV: Considering The Low-Maintenance Option To Navigate The Healthcare Sector Lilly, Zoetis, Abbott least shor...
MOUNTAIN VIEW, Calif., Feb. 01, 2024 (GLOBE NEWSWIRE) -- IGM Biosciences, Inc. (Nasdaq: IGMS), a clinical-stage biotechnology company creating and developing engineered IgM antibodies, today announced that Fred Schwarzer, Chief Executive Officer, will participate in a fireside chat at the Guggenh...
2024-01-30 16:22:00 ET Stock Traders Daily has produced this trading report using a proprietary method. This methodology seeks to optimize the entry and exit levels to maximize results and limit risk, and it is also applied to Index options, ETFs, and futures for our subscribers. This...
2024-01-05 05:50:19 ET Summary IGM Biosciences is developing antibodies that are different from most monoclonal antibodies currently in use. They have two main pipeline projects focused on cancer and rheumatologic disease. The company is facing financial challenges but has ext...
MOUNTAIN VIEW, Calif., Jan. 03, 2024 (GLOBE NEWSWIRE) -- IGM Biosciences, Inc. (Nasdaq: IGMS), a clinical-stage biotechnology company creating and developing engineered IgM antibodies, today announced that Fred Schwarzer, Chief Executive Officer, will present at the 42 nd Annual J.P. Morgan H...
2023-12-14 04:20:00 ET Stock Traders Daily has produced this trading report using a proprietary method. This methodology seeks to optimize the entry and exit levels to maximize results and limit risk, and it is also applied to Index options, ETFs, and futures for our subscribers. This...
2023-12-08 16:43:19 ET Gainers: IGM Biosciences, Inc. ( IGMS ) +9% . EF Hutton Acquisition Corporation I ( EFHT ) +6% . Biomea Fusion ( BMEA ) +5% . Larimar Therapeutics ( LRMR ) +2% . First Solar ( FSLR ) +1% . Losers: L...
2023-12-06 12:40:32 ET More on Medivir AB Historical earnings data for Medivir AB Financial information for Medivir AB For further details see: Medivir says IGM Biosciences cutbacks won't impact lead product fostrox
News, Short Squeeze, Breakout and More Instantly...
IGM Biosciences Inc. Company Name:
IGMS Stock Symbol:
NYSE Market:
- Enrollment target exceeded in aplitabart randomized colorectal cancer clinical trial - - Enrollment completed in first dose cohort in imvotamab rheumatoid arthritis clinical trial - MOUNTAIN VIEW, Calif., May 08, 2024 (GLOBE NEWSWIRE) -- IGM Biosciences, Inc. (Nasdaq: IGMS), a c...
MOUNTAIN VIEW, Calif., May 07, 2024 (GLOBE NEWSWIRE) -- IGM Biosciences, Inc. (Nasdaq: IGMS), a clinical-stage biotechnology company creating and developing engineered IgM antibodies, today announced that management will participate in a fireside chat at the 2024 RBCCM Global Healthcare Conferenc...
Investors might want to bet on IGM Biosciences, Inc. (NASDAQ: IGMS), as it has been recently upgraded to a Zacks Rank #2 (Buy). An upward trend in ...